Navigation Links
Make Meth Ingredients Prescription-Only Says Former White House Drug Spokesman Bob Weiner; Oregon Did and Cut Crisis by Half
Date:6/1/2010

WASHINGTON, June 1 /PRNewswire-USNewswire/ -- Former White House Drug Policy Spokesman Robert Weiner and Jonathan Battaglia, a Policy Analyst at Robert Weiner Associates, say that Congress and state legislatures should make methamphetamine's main ingredient, pseudoephedrine, prescription-only.  In an op-ed in The State, South Carolina's largest newspaper, Weiner and Battaglia say Oregon has taken the step and in three years since 2006 enactment, cut the crisis in half. Mississippi and Missouri have recently taken similar steps.

Weiner and Battaglia point out that methamphetamine is a dangerous, illicit drug that 10.4 million Americans aged 12 or older have tried at least once.

"The best way to curtail meth use is to make sure the only people getting pseudoephedrine, a key component of meth found in most over-the-counter cold medications, are the people who really need it," Weiner and Battaglia say.

"It's time lawmakers make the problem a legislative priority."

The authors quote former U.S. Drug Czar Barry McCaffrey, who has called meth "one of the worst drug menaces ever to threaten America, associated with paranoia, stroke, heart attack, and permanent brain damage, leaving a trail of crime and death."

They note the support of Drug Czar Gil Kerlikowske: "I am unbelievably supportive of making pseudoephedrine prescription-only," Kerlikowske responded to Weiner's question on the subject at the National Press Club May 12. Kerlikowske also told Congress in April that the experiment in Oregon has been "very encouraging" and "a huge victory."

The co-authors make the point that the current federal legislation, the Combat Methamphetamine Epidemic Act, does not go far enough with daily and monthly sales limits for pseudoephedrine. "The result was a confusing process for retailers and the arrests of law-abiding people with no other motive but getting rid of their cold or allergies. An Illinois man was arrested for going over the monthly legal limit because he had to buy enough Claritin-D for himself and his son. Arresting a man for treating his allergies is not the intent of this law."

Weiner and Battaglia conclude by saying, "South Carolina, other states, and Congress should follow suit" to Oregon and make pseudoephedrine prescription-only.

Link to Article:

http://www.thestate.com/2010/05/30/1307846/battaglia-weiner-make-meth-ingredients.html

Contact: Bob Weiner/Rebecca Vander Linde 301-283-0821/202-306-1200


'/>"/>
SOURCE Robert Weiner Associates
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tainted Chinese Food Ingredients First Discovered in 2005
2. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
3. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
4. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
5. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
6. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
7. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
8. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
9. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
10. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
11. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):